Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Alcoa Corporation's fourth quarter and full-year 2024 earnings report presents a multifaceted picture of the company's performance and future outlook, highlighting both positive achievements and areas of concern.</li><li>In 2024, Alcoa achieved significant operational and financial milestones.</li><li>The company witnessed improved safety metrics and recorded no fatalities or life-altering injuries, which underscores its commitment to creating a safer work environment.</li></ul>

Alcoa Corporation's fourth quarter and full-year 2024 earnings report presents a multifaceted picture of the company's performance and future outlook, highlighting both positive achievements and areas of concern.In 2024, Alcoa achieved significant operational and financial milestones.The company witnessed improved safety metrics and recorded no fatalities or life-altering injuries, which underscores its commitment to creating a safer work environment.

Alcoa’s Surprising Bauxite Boom: The Hidden Catalyst Driving Market Domination! - Major Drivers

Chief Economist & Political Strategist, CrossASEAN Research

Prasenjit K. Basu

Chief Economist & Political Strategist

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Macroeconomics

<ul>
<li>US tariff agreements have contained tariffs at 10% for the UK, 15% for Japan and the EU, 19% for Indonesia and 20% for Vietnam. Lower tariffs will dampen inflation. </li>
<li>FOMC ought to cut rates now, but may stand on ceremony. The tariffs are nonetheless likely to steadily bolster US manufacturing in H2/2025, with Jun'25 steel output already up 4.6%YoY. </li>
<li>With growth higher than expected, and new revenues of over US$300bn from tariffs, the fiscal deficit should fall below 6% of GDP, allowing bond yields to moderate below 4%. </li>
</ul>


US tariff agreements have contained tariffs at 10% for the UK, 15% for Japan and the EU, 19% for Indonesia and 20% for Vietnam. Lower tariffs will dampen inflation. 
FOMC ought to cut rates now, but may stand on ceremony. The tariffs are nonetheless likely to steadily bolster US manufacturing in H2/2025, with Jun'25 steel output already up 4.6%YoY. 
With growth higher than expected, and new revenues of over US$300bn from tariffs, the fiscal deficit should fall below 6% of GDP, allowing bond yields to moderate below 4%. 


US: Tariff Deals with Japan, EU, Indonesia, Philippines Sharply Reduce Stagflation Risk

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>I tally 50 - mostly firm, mostly Asia-Pac - transactions currently being discussed and analysed on Smartkarma. Inside is a timetable of upcoming key events for each deal.</li>
<li>Three new deals discussed this week: <a href="https://www.smartkarma.com/entities/fancl-corp" target="_blank" data-smartkarma-citation="entities:15862:1" rel="noopener">Fancl (4921 JP)</a>'s Tender offer, <a href="https://www.smartkarma.com/entities/a8-new-media-group-ltd" target="_blank" data-smartkarma-citation="entities:3444:1" rel="noopener">A8 New Media (800 HK)</a>'s Scheme, and <a href="https://www.smartkarma.com/entities/jeisys-medical-inc" target="_blank" data-smartkarma-citation="entities:36766:1" rel="noopener">Jeisys Medical (287410 KS)</a>'s delisting offer. Bain also approached <a href="https://www.smartkarma.com/entities/bapcor-ltd" target="_blank" data-smartkarma-citation="entities:8433:1" rel="noopener">Bapcor (BAP AU)</a>.</li>
<li>Key updates took place on: <a href="https://www.smartkarma.com/entities/sigma-healthcare-ltd" target="_blank" data-smartkarma-citation="entities:15966:1" rel="noopener">Sigma Healthcare (SIG AU)</a>, <a href="https://www.smartkarma.com/entities/alumina-ltd" target="_blank" data-smartkarma-citation="entities:939:1" rel="noopener">Alumina (AWC AU)</a>, <a href="https://www.smartkarma.com/entities/greatview-aseptic-packaging" target="_blank" data-smartkarma-citation="entities:10802:1" rel="noopener">Greatview Aseptic Packaging (468 HK)</a>, <a href="https://www.smartkarma.com/entities/helios-techno-holding-co-ltd" target="_blank" data-smartkarma-citation="entities:13934:1" rel="noopener">Helios Techno (6927 JP)</a>, and <a href="https://www.smartkarma.com/entities/tatsuta-electric-wire-cable-co-ltd" target="_blank" data-smartkarma-citation="entities:12509:1" rel="noopener">Tatsuta Electric Wire &amp; Cable (5809 JP)</a>.</li>
</ul>


I tally 50 - mostly firm, mostly Asia-Pac - transactions currently being discussed and analysed on Smartkarma. Inside is a timetable of upcoming key events for each deal.
Three new deals discussed this week: Fancl (4921 JP)'s Tender offer, A8 New Media (800 HK)'s Scheme, and Jeisys Medical (287410 KS)'s delisting offer. Bain also approached Bapcor (BAP AU).
Key updates took place on: Sigma Healthcare (SIG AU), Alumina (AWC AU), Greatview Aseptic Packaging (468 HK), Helios Techno (6927 JP), and Tatsuta Electric Wire &amp; Cable (5809 JP).


(Mostly) Asia-Pac M&A: Fancl, Jeisys Medical, A8 New Media, Bapcor, Helios Techno,Tatsuta Electric

Asia L/S Equity PM/Macro/Thematic Idea Generation

Rikki Malik

Citic Resources Holdings / Equity Bottom-Up

<ul>
<li>One of a basket of Hong Kong commodity stocks we like</li>
<li>One off issues in 2023 which should reverse in 2024</li>
<li>Can also be viewed as  a tangential play on India's industrial growth</li>
</ul>


One of a basket of Hong Kong commodity stocks we like
One off issues in 2023 which should reverse in 2024
Can also be viewed as  a tangential play on India's industrial growth


Citic Resource Holdings (1205.HK) - A Play on Oil and Coal Demand

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

US Treasury (10 Yr Generic) / Technical Analysis

<ul>
<li>We maintain our near-term bullish outlook on S&amp;P 500 (SPX) and Nasdaq 100 (QQQ), which has remained in place since 4/22/25, aside from one week (11/19/25-11/25/25) when we were neutral.</li>
<li>Our intermediate-term bullish outlook has been in place since 5/14/25. We'll stay near-term bullish as long as crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ hold.</li>
<li>Additionally, as discussed last week (12/2/25) we believe SPX, QQQ, and Russell 2000 (IWM) are in the midst of a new lockout rally, which is likely to run through early-2026</li>
</ul>


We maintain our near-term bullish outlook on S&amp;P 500 (SPX) and Nasdaq 100 (QQQ), which has remained in place since 4/22/25, aside from one week (11/19/25-11/25/25) when we were neutral.
Our intermediate-term bullish outlook has been in place since 5/14/25. We'll stay near-term bullish as long as crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ hold.
Additionally, as discussed last week (12/2/25) we believe SPX, QQQ, and Russell 2000 (IWM) are in the midst of a new lockout rally, which is likely to run through early-2026


Rising Yields a Problem?; Russell 2000 Breakout; No Concern if 10Y Treasury Yield Is Below 4.2%

United States

Alcoa Corporation manufactures metal products. The Company produces and sells bauxite, alumina, and aluminum products. Alcoa serves aluminum industry worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Alcoa (AA US)

Alcoa’s Surprising Bauxite Boom: The Hidden Catalyst Driving Market Domination! - Major Drivers

Alcoa Corporation's fourth quarter and full-year 2024 earnings report presents a multifaceted picture of the company's performance and future...

Baptista Research

US: Tariff Deals with Japan, EU, Indonesia, Philippines Sharply Reduce Stagflation Risk

US tariff deals lowering them will help dampen inflation, and should trigger rate cuts. Tariffs are already boosting US manufacturing, thus will...

Prasenjit K. Basu

(Mostly) Asia-Pac M&A: Fancl, Jeisys Medical, A8 New Media, Bapcor, Helios Techno,Tatsuta Electric

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett

Citic Resource Holdings (1205.HK) - A Play on Oil and Coal Demand

A HK commodity stock with earnings expected to improve over the next few years - also tied to India's industrial growth.

Rikki Malik

Rising Yields a Problem?; Russell 2000 Breakout; No Concern if 10Y Treasury Yield Is Below 4.2%

Rising Yields a Problem?; Russell 2000 $IWM Breakout; No Concern if 10Y Treasury Yield is below 4.2%, and quite possibly 4.35%-4.50% if MOVE index...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Alcoa’s Surprising Bauxite Boom: The Hidden Catalyst Driving Market Domination! - Major Drivers

Alcoa Corporation's fourth quarter and full-year 2024 earnings report presents a multifaceted picture of the company's performance and future...

Baptista Research

US: Tariff Deals with Japan, EU, Indonesia, Philippines Sharply Reduce Stagflation Risk

​US tariff deals lowering them will help dampen inflation, and should trigger rate cuts. Tariffs are already boosting US manufacturing, thus will...

Prasenjit K. Basu

(Mostly) Asia-Pac M&A: Fancl, Jeisys Medical, A8 New Media, Bapcor, Helios Techno,Tatsuta Electric

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett

Citic Resource Holdings (1205.HK) - A Play on Oil and Coal Demand

A HK commodity stock with earnings expected to improve over the next few years - also tied to India's industrial growth.

Rikki Malik

Rising Yields a Problem?; Russell 2000 Breakout; No Concern if 10Y Treasury Yield Is Below 4.2%

Rising Yields a Problem?; Russell 2000 $IWM Breakout; No Concern if 10Y Treasury Yield is below 4.2%, and quite possibly 4.35%-4.50% if MOVE index...

Vermilion Research

US tariff deals lowering them will help dampen inflation, and should trigger rate cuts. Tariffs are already boosting US manufacturing, thus will...